Skip to Content

MYLAN 8008 MYLAN 8008 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint MYLAN 8008 MYLAN 8008 is Purple / White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint:
MYLAN 8008 MYLAN 8008
Strength:
125 mg
Color:
Purple / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-8008

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide